Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : Ms save search
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
Published: 2024-04-18 (Crawled : 10:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.43%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: -2.19%
H: 0.96%
C: -1.72%
million offering
Intra-Cellular Therapies Prices Public Offering of Common Stock - April 18, 2024
Published: 2024-04-18 (Crawled : 06:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.43%
H: 0.0%
C: 0.0%
ITCI | News 0 d | $72.01 -6.1% -6.5% 4.7M
|
Health Technology
|
| O: -4.8%
H: 0.0%
C: 0.0%
offering
Intra-Cellular Therapies Prices Public Offering of Common Stock
Published: 2024-04-18 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.43%
H: 0.0%
C: 0.0%
ITCI | News 0 d | $72.01 -6.1% -6.5% 4.7M
|
Health Technology
|
| O: -4.8%
H: 0.0%
C: 0.0%
offering
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.14%
H: 0.0%
C: 0.0%
ITCI | News 0 d | $72.01 -6.1% -6.5% 4.7M
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
offering
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Published: 2024-04-11 (Crawled : 11:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.74%
H: 0.09%
C: -5.32%
LPCN | $5.47 2.82% 2.74% 21K
|
Health Technology
|
| O: 6.78%
H: 13.49%
C: 1.75%
obesity positive results
New Nationwide Study Finds Majority of Hispanic & Latino/a Employees in the U.S. Experience Pressure to Assimilate and Downplay Aspects of their Personality in Order to Succeed at Work
Published: 2024-04-10 (Crawled : 21:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.74%
H: 0.09%
C: -5.32%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
work order nationwide study
Arcutis Appoints David Topper as Chief Financial Officer
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -1.43%
H: 0.0%
C: 0.0%
ARQT A | $9.45 -7.81% -8.47% 2.9M
|
Health Technology
|
| O: -6.11%
H: 5.83%
C: 4.73%
financial
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Contineum Therapeutics Announces Pricing of Initial Public Offering
Published: 2024-04-05 (Crawled : 01:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
Published: 2024-04-03 (Crawled : 06:00) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: -1.12%
H: 0.58%
C: -1.34%
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.26%
H: 1.45%
C: 0.05%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -2.04%
H: 1.12%
C: -0.17%
acquisition
AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING
Published: 2024-03-28 (Crawled : 13:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.27%
H: 1.05%
C: 0.44%
JAZZ | $109.3 2.05% 2.01% 560K
|
Health Technology
|
| O: 0.0%
H: 0.85%
C: -0.07%
first million pharmaceuticals
Cytek® Biosciences Names William McCombe Chief Financial Officer
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CTKB 4 | $5.97 0.85% 0.84% 670K
|
Health Technology
|
| O: -1.03%
H: 1.86%
C: -0.45%
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.05%
H: 1.24%
C: 0.48%
cytek financial
Genmab Announces Initiation of Share Buy-Back Program
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: -1.89%
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.7%
H: 0.98%
C: -0.11%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -0.59%
H: 0.33%
C: -0.6%
program
Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends
Published: 2024-03-14 (Crawled : 00:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.39%
H: 0.45%
C: 0.11%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 2.35%
H: 2.3%
C: -1.15%
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: -1.63%
H: 0.55%
C: -0.55%
report contract royalty trends deal
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-08 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
| Email alert
Add to watchlist
AKRO | $20.535 -4.93% -5.19% 760K
|
Health Technology
| Email alert
Add to watchlist
offering therapeutics
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
Published: 2024-03-07 (Crawled : 05:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.49%
H: 1.21%
C: 0.07%
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: -2.58%
H: 1.37%
C: -0.64%
offering
Akero Therapeutics Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.535 -4.93% -5.19% 760K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
Published: 2024-03-06 (Crawled : 03:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.535 -4.93% -5.19% 760K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Published: 2024-03-04 (Crawled : 22:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
VKTX | $64.7 -2.66% -2.74% 2.4M
|
Health Technology
|
| O: -1.47%
H: 3.24%
C: -2.33%
LGND | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: -0.75%
H: 1.55%
C: -2.26%
offering therapeutics
Akero Therapeutics Announces Proposed Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.94%
H: 2.19%
C: -0.07%
AKRO | $20.535 -4.93% -5.19% 760K
|
Health Technology
|
| O: -1.03%
H: 1.95%
C: -0.75%
offering therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.